Document:

<PAGE>

                                                                     Exhibit 4.2

                             STOCKHOLDERS AGREEMENT

         This Stockholders Agreement (the "Agreement") is made and entered into
at on February 25, 1998 by and between LINDSAY A. ROSENWALD, M.D. (the
"Investor"), DR. STUART WEG, HERBERT BROTSPIES and CALGAR & ASSOCIATES
(collectively the "Licensors") and PAIN MANAGEMENT, INC. (the "Company").

                                    RECITALS

         WHEREAS, the Company's authorized capital structure consists of twenty
five million (25,000,000) shares of common stock, par value $.001 per share (the
"Common Stock") and ten million (10,000,000) shares of preferred stock;

         WHEREAS, it is the intention of the parties hereto that the Investor
shall be allocated seventy-five percent (75%) of the shares of Common Stock
initially issued by the Company and Licensors shall be allocated twenty-five
percent (25%) of the shares of Common Stock initially issued by the Company,
which together shall constitute the entire issued capital of the Company (the
"Stock").

         WHEREAS, the Company has previously entered into a License Agreement
with Dr. Stuart Weg, which is attached hereto as Exhibit A (the "License
Agreement") relating to "Nasal Administration of Ketamine to Manage Pain" (the
"Invention").

         NOW THEREFORE, it is hereby agreed between the parties hereto as
follows:

1.       Issue of shares: Registration

         (a) The Company shall issue to the Investor a number of shares of
Common Stock equal to seventy-five percent (75%) of the Stock. The Company shall
issue to the Licensors a number of shares of Common Stock equal to twenty-five
percent (25%) of the Stock. Twenty percent (20%) of such shares shall be
immediately issued to the Licensor and/or his representatives to be distributed
as follows: (i) seventeen percent (17%) to Dr. Stuart Weg; (ii) one and one-half
percent (1.5%) to Herbert Brotspies and (iii) one and one-half percent (1.5%) to
Calgar and Associates. As soon as practicable after the execution of this
Agreement, the Company shall take all necessary steps to cause the issuance of
the Stock.

         (b) Of the shares of Common Stock to be issued to the Licensors and/or
his representatives, the Company shall hold in escrow a number of such shares of
Common Stock equal to five percent (5%)of the initial share capital of the
Company (the "Escrow Shares"). The Escrow Shares shall vest, if at all, and be
released from escrow upon completion of a statistically significant Phase III
clinical trial and shall be distributed as follows: (i) four and one-quarter
percent (4.25%) to the Licensor; (ii) three hundred seventy-five one-hundredths
percent (0.375%) to Herbert Brotspies and (iii) three hundred seventy-five
one-hundredths percent (0.375%) to Calgar and Associates.

                                       1
<PAGE>

         (c) The Company agrees that if, at any time, and from time to time,
after the initial public offering (the "IPO") of the Company's Common Stock and
ending on the date that is five (5) years from the date hereof, the Board of
Directors of the Company shall authorize the filing of a registration statement
under the Act (other than the initial public offering of the Company's Common
Stock, or other than a registration statement on Form S-8, Form S-4 or any other
form that does not include substantially the same information as would be
required in a form for the general registration of securities) in connection
with the proposed offer of any of its securities by it or any of its
stockholders, the Company shall, (i) promptly notify the Licensors that such
registration statement will be filed and that the Registrable Securities then
held by the Licensors will be included in such registration statement at the
Licensors' request, (ii) cause such registration statement to cover all of such
Registrable Securities issued to the Licensors requesting inclusion, (iii) use
its reasonable best efforts to cause such registration statement to become
effective as soon as practicable and (iv) take all other action necessary under
any Federal or state law or regulation of any governmental authority to permit
all such Registrable Securities that have been issued to the Licensors to be
sold or otherwise disposed of, and will maintain such compliance with each such
Federal and state law and regulation of any governmental authority for the
period necessary for the Licensors to effect the proposed sale or other
disposition.

          (d) Notwithstanding any other provision herein, the Company may at any
time, abandon or delay any registration commenced by the Company. In the event
of such an abandonment by the Company, the Company shall not be required to
continue registration of shares requested by the Licensors for inclusion and
the Licensors shall retain the right to request inclusion of shares as set forth
above.

          (e) The Licensors shall have the right to request inclusion of any of
their shares of Common Stock in a registration statement as described above up
to two (2) times; provided, however, that an abandoned registration statement
shall not be counted as a request by the Licensors for inclusion.

          (f) The right of any Licensors to request inclusion in any
registration pursuant to this Agreement shall terminate if all shares of Common
Stock held by the Licensors may immediately be sold under Rule 144 or Rule 701
during any 90-day period.

                                       2
<PAGE>

2. Fund Raising

         (a) The Company shall use its reasonable efforts to consummate a
private placement (a "Private Placement") of debt or equity securities of the
Company or otherwise attain net assets in excess of two million dollars
($2,000,000) within one (1) year from the date of execution of this Agreement.
The Company agrees that it will use its reasonable efforts to conduct any such
Private Placement at a pre-money value equal to two million dollars
($2,000,000).

         (b) In the event that the Company has not obtained financing (or
otherwise obtained net assets) in excess of two million dollars ($2,000,000)
within one (1) year from the date hereof, then the Licensor at his option may
terminate the License Agreement upon ten (10) days notice to the Company. If the
License Agreement is so terminated the Company shall have the right to
repurchase the Common Stock issued to the Licensor pursuant to Section 1(a) and
(b) at a price per share equal to $.001.

3.       Sales by Investor:

         (a) Subject to paragraph 3(g) below, if the Investor proposes to sell
any of his Stock or receives an offer from an unaffiliated third party in one or
more related transactions (each a "Sale"), then the Investor shall promptly give
written notice (the "Notice") to the Company and to Licensors on or before the
earlier to occur of (i) five (5) days after the contract date and (ii) twenty
(20) days prior to the closing of such sale. The Notice shall describe in
reasonable detail the proposed sale including, without limitations, the number
of shares of Stock to be sold, the consideration to be paid, and the name and
address of each prospective purchaser.

         (b) Licensors shall have the right, exercisable upon written notice to
the Investor within fifteen (15) days after receipt of the Notice, to
participate in such sale including on the same terms and conditions specified in
the Notice. To the extent that Licensors exercise such right of participation in
accordance with the terms and conditions as set forth below, the number of
shares that the Investor may sell in the transaction shall be correspondingly
reduced.

         (c) Licensors may sell all or any part of that number of shares of
Stock owned by each, respectively, equal to the product obtained by multiplying
(i) the aggregate number of shares covered by the Notice by a (ii) a fraction,
the numerator of which is the number of shares of Stock owned by Licensors at
the time of the sale and the denominator of which is the total number of shares
of Stock owned by Licensors and the Investor at the time of the sale. For
example, if the Investor notifies Licensors of his intention to sell one hundred
thousand (100,000) shares of Stock, and at that time, the Investor and Licensors
own nine million (9,000,000) and one million (1,000,000) shares of Stock,
respectively, Licensors would be entitled to sell up to one tenth (1/10) of the
shares covered by such notice or ten thousand (10,000) shares.

                                       3
<PAGE>

         (d) Licensors shall effect participation in the sale by promptly
delivering to the Investor for the transfer to the prospective purchaser one or
more certificates, properly endorsed for transfer, which represent the number of
shares of Stock which Licensors elects to sell.

         (e) The stock certificate or certificates that Licensors deliver to the
Investor pursuant to paragraph 3(d) shall be transferred to the respective
purchaser in consummation of the sale of the Stock pursuant to the terms and
conditions specified in the Notice, and the Investor shall concurrently
therewith remit to Licensors that portion of the sales proceeds to which
Licensors is entitled by reason of its participation in such sale.

         (f) To the extent that Licensors elect not to participate in any such
Sale, the Investor may enter into an agreement providing for the closing of the
transfer of the Stock covered by the Notice on terms and conditions not more
favorable than those described in the Notice.

         (g) The Investor's obligations, and the co-sale rights of Licensors,
under this section 3 shall terminate immediately upon the earlier to occur of
(i) any sale of the Company's Common Stock to the public pursuant to a
registration statement filed with, and declared effective by, the Securities and
Exchange Commission ("SEC") under the Securities Act of 1933, as amended (the
"Act") (a "Public Offering") and (ii) the first date on which the Common Stock
of the Company (or securities received in exchange for Common Stock of the
Company) trades on a national securities exchange, on the National Association
of Security Dealers, Inc. Automated Quotations System ("NASDAQ") or on the OTC
Electronic Bulletin Board or in "pink sheets" (a "Trading Date").

4.       Exempt Transfers:

         Notwithstanding the foregoing, the provisions of the above paragraph 3
shall not apply to (a) any pledge of Stock made pursuant to a bona fide loan
transaction that creates a security interest provided that such transaction is
not consummated solely for the purpose of avoiding the co-sales rights of
Licensors contained herein or (b) sales (i) to the public pursuant to a
registration statement filed with, and declared effective by, the SEC under the
Act, or any sales made thereafter, (ii) to the Company or an Affiliate of the
Company (as defined in the Subscription Agreement) or (iii) to a purchaser,
merging or consolidating corporation, or acquiror of more than fifty percent
(50%) of the Company's assets or business.

5.       Term of Agreement

         The Co-sale rights set forth in this Agreement shall terminate upon the
earlier to occur of (a) a Public Offering of the shares of the Company's Common
Stock and (b) a Trading Date.

                                       4
<PAGE>

6.       Miscellaneous

         (a) This Agreement shall be governed by and interpreted in accordance
with the laws of the State of New York, without regard to principles of
conflicts of law, and exclusive jurisdiction shall be granted to the appropriate
court in New York.

         (b) Disputes arising between the parties which can not be settled
satisfactorily between the parties, shall be finally determined by arbitration
in New York, New York.

         (c) Any notice or other communication required or authorized to be
given by any party under this Agreement to the other party shall be in writing
and shall be personally delivered, sent by telex or facsimile transmission (with
a copy by airmail in either case) or sent by registered airmail addressed to the
other party at the address stated below or such other address as shall be
specified by the parties hereto by notice in accordance with the provisions of
this paragraph. Any notice shall operate and be deemed to have been served at
the expiration of fourteen (14) days after it is posted or on the next following
business day if sent by telex, facsimile transmission or personally delivered;
provided, however, that any notice of change of address shall be effective only
upon receipt.

         Addresses for the purposes of this section are as follows:

Investor:                   Lindsay A. Rosenwald, M.D.
                            c/o Paramount Capital Investments, LLC
                            787 Seventh Avenue
                            New York, New York 10019
                            Attn:  Michael S. Weiss
                            Fax:   212-554-4490

Dr. Stuart Weg:             498 Island Way
                            Franklin Lakes, N.J.
                            Attn:  Dr. Stuart Weg
                            Tel:   201-848-9344
                            Fax:   201-848-1805

Herbert Brotspies:          Herbert Brotspies
                            17 Marline Ave E
                            Edison, NJ
                            Attn:  Herbert Brotspies
                            Tel:   732-321-0456
                            Fax:   732-906-7653

                                       5
<PAGE>

Calgar & Associates:        44 Dale Drive
                            Edison, New Jersey 08820
                            Attn:   Dr. Herbert Gary
                            Tel:    908-548-0996
                            Fax:    908-603-7976

The Company:                Pain Management, Inc.
                            c/o Paramount Capital Investments, LLC
                            787 Seventh Avenue, 48th Floor
                            New York, New York 10019
                            Ann:    Michael S. Weiss
                            Tel:    212-554-4350
                            Fax:    212-554-4355

         (d) This Agreement may be executed in two or more counterparts each of
which shall be deemed an original but all of which constitute one and the same
instrument.

         (e) Nothing in this Agreement is intended to vest, or shall be
construed as vesting, any rights, financial, legal or otherwise, in any person
not a party hereto.

         (f) The headings of sections herein are for convenient reference only
and shall in no way affect the meaning of this Agreement. Section and
sub-section references are to sections and sub-sections of this Agreement unless
explicitly stated otherwise.

         (g) This Agreement may be amended or terminated, and any of the terms
hereof may be waived, only by a document in writing specifically referring to
this Agreement and executed by the parties hereto or, in the case of a waiver,
by the party waving compliance;

         (h) In the event that it is not possible to reach the stage of the
commercial development, production and marketing, then the parties shall
terminate the License Agreement in accordance with the terms thereof. After
reimbursement of all Company expenses, any amounts remaining in the Company
shall first be returned to the Investor, up to the total amount of his
investment in the Company and then to the Licensors up to the total amount of
their investment in the Company. The funds remaining in the Company thereafter,
shall be distributed proportionally according to the percentage of shares held
by each shareholder on the date of termination.

         (i) The parties hereto agree to execute documents and perform such
further acts as may be necessary to bring this Agreement into full force and
effect.

         (j) This Agreement represents the sole and entire agreement between the
parties hereto with respect of the transactions contemplated herein, and
supersedes all prior discussions and agreements among the parties hereto.

                                       6
<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Agreement the day
and year first before written.

                                     LINDSAY A. ROSENWALD, M.D.

                                      By: /s/ LINDSAY A. ROSENWALD
                                          --------------------------------------
                                      Name:

                                      DR. STUART WEG

                                      By: /s/ STUART WEG
                                          --------------------------------------
                                      Name:

                                      HERBERT BROTSPIES

                                      By:  /s/ HERBERT BROTSPIES
                                          --------------------------------------
                                      Name:   Herbert Brotspies

                                      CALGAR & ASSOCIATES

                                      By: /s/ HERBERT GARY
                                          --------------------------------------
                                      Name: Herbert Gary
                                      Its:

                                      PAIN MANAGEMENT, INC.

                                      By: /s/ MICHAEL S. WEISS
                                          --------------------------------------
                                      Name:  Michael S. Weiss
                                      Its:   Sole Director

                                       7<PAGE>
                                                                     Exhibit 4.3

                     INNOVATIVE DRUG DELIVERY SYSTEMS, INC.
                        2000 OMNIBUS STOCK INCENTIVE PLAN

                  This 2000 Omnibus Stock Incentive Plan (the "Plan") is
established by Innovative Drug Delivery Systems, Inc., a Delaware corporation
(the "Company"), effective as of March 12, 2002 (the "Effective Date"), subject
to the approval of the shareholders of the Company within twelve (12) months
thereafter.

                  1. Purpose. The Plan is intended to provide qualifying
Employees, Directors and Consultants with equity ownership in the Company,
thereby strengthening their commitment to the success of the Company, promoting
the identity of interests between the Company's shareholders and such Employees,
Directors and Consultants and stimulating their efforts on behalf of the
Company, and to assist the Company in attracting and retaining talented
personnel.

                  2. Scope of the Plan.

                     (a) Subject to adjustment as set forth in subsection (b)
below and in accordance with Section 21, the total number of Shares which may be
issued pursuant to Awards under the Plan is 4,200,000. In accordance with the
requirements of Section 162(m) of the Code, the number of Shares for which
Awards may be granted to any individual Grantee in any calendar year shall not
exceed 1,000,000. If any Shares subject to any Award granted hereunder are
forfeited or such Award otherwise terminates without the issuance of such Shares
or for other consideration in lieu of such Shares, the Shares subject to such
Award, to the extent of any such forfeiture or termination, shall again be
available for grant under the Plan. If any outstanding ISOs under the Plan for
any reason expire or are terminated, the Shares allocable to the unexercised
portion of all of such ISOs may again be subject to the ISOs under the Plan.
Shares awarded under the Plan may be treasury shares or newly-issued shares.

                     (b) Following the date on which the Company becomes a
Public Company, the number of Shares which may be issued pursuant to Awards
under the Plan shall automatically increase on the first trading day of January
each calendar year during the term of the Plan, beginning with calendar year
2003, by an amount equal to three percent (3%) of the total number of Shares
outstanding on the last trading day in December of the immediately preceding
calendar year, but in no event shall any such annual increase exceed 1,000,000
shares.

                  3. Administration.

                     (a) Except with respect to Section 7 below (Automatic
Option Grants), the Plan shall be administered by a Committee which shall
consist of at least two or more members of the Board, all of whom, commencing
with the date on which the Company becomes a Public Company, may qualify as
"outside directors" as defined for purposes of the regulations under Section
162(m) of the Code and as "non-Employee directors" under Section (b)(3)(i) of
Rule 16b-3. Commencing with the date on which the Company becomes a Public
Company, the number of members of the Committee shall from time to time be
increased or decreased, and shall be subject to such conditions, in each case as
the Board deems appropriate to permit transactions in Shares pursuant to the
Plan to satisfy such conditions of Rule 16b-3 and Section 162(m) of the Code as
then in effect. Notwithstanding anything to the contrary in this Plan, the
Committee may be comprised of the entire Board. The Automatic Option Grant
Program described in Section 7 below shall be self-executing in accordance with
its terms, and the Committee shall not exercise any discretionary authority with
respect to any grants made under that program.

<PAGE>

                     (b) Subject to the express provisions of the Plan, the
Committee has full and final authority and discretion as follows:

                         (i) to determine when and to whom Awards should be
granted and the terms, conditions and restrictions applicable to each Award,
including, without limitation, (A) the exercise price of the Award, (B) the
method of payment for Shares purchased upon the exercise of the Award, (C) the
method of satisfaction of any tax withholding obligation arising in connection
with the Award, (D) the timing, terms and conditions of the exercisability of
the Award or the vesting of any Shares acquired upon the exercise thereof, (E)
the time of the expiration of the vesting of any Shares acquired upon the
exercise thereof, (F) the effect of the Grantee's termination of employment or
service with the Company on any of the foregoing, (G) all other terms,
conditions and restrictions applicable to the Award or such Shares not
inconsistent with the terms of the Plan, (H) the benefit payable under any SAR
or Performance Share, and (I) whether or not specific Awards shall be identified
with other specific Awards, and if so whether they shall be exercisable
cumulatively with, or alternatively to, such other specific Awards;

                         (ii) to determine the amount, if any, that a Grantee
shall pay for Restricted Shares, whether to permit or require the payment of
cash dividends thereon to be deferred and the terms related thereto, when
Restricted Shares (including Restricted Shares acquired upon the exercise of any
Award) shall be forfeited and whether such Shares shall be held in escrow;

                         (iii) to interpret the Plan and to make all
determinations necessary or advisable for the administration of the Plan;

                         (iv) to make, amend and rescind rules, guidelines and
policies relating to the Plan, or to adopt supplements to, or alternative
versions of the Plan, including, without limitation, rules with respect to the
exercisability and forfeitability of Awards upon the termination of employment
or service of a Grantee;

                         (v) to determine the terms, conditions and restrictions
of all Award Agreements (which need not be identical) and, with the consent of
the Grantee, to amend any such Award Agreement at any time, among other things,
to permit transfers of such Awards to the extent permitted by the Plan, except
that the consent of the Grantee shall not be required for any amendment which
(A) does not adversely affect the rights of the Grantee or (B) is necessary or
advisable (as determined by the Committee) to carry out the purpose of the Award
as a result of any change in applicable law;

                         (vi) to cancel, with the consent of the Grantee,
outstanding Awards and to grant new Awards in substitution therefor;

                                       2
<PAGE>

                         (vii) to accelerate the exercisability of, and to
accelerate or waive any or all of the terms, conditions and restrictions
applicable to, any Award or any group of Awards for any reason and at any time,
including in connection with a termination of employment (other than for Cause);

                         (viii) subject to Section 6(c), to extend the time
during which any Award or group of Awards may be exercised;

                         (ix) to make such adjustments or modifications to
Awards to Grantees working outside the United States as are advisable to fulfill
the purposes of the Plan;

                         (x) to impose such additional terms, conditions and
restrictions upon the grant, exercise or retention of Awards as the Committee
may, before or concurrent with the grant thereof, deem appropriate; and

                         (xi) to take any other action with respect to any
matters relating to the Plan for which it is responsible.

The determination of the Committee on all matters relating to the Plan or any
Award Agreement shall be final.

                  4. Indemnification and Reimbursement. Service as a member of
the Committee or any other duly appointed committee shall constitute service as
a Board member, and such members shall accordingly be entitled to full
indemnification and reimbursement as Board members for their service as members
of the Committee or any other duly appointed committee. No Committee or other
duly appointed committee member shall be liable for any act or omission made in
good faith with respect to the Plan or any Award granted under the Plan.

                  5. Eligibility. The Committee may, in its discretion, grant
Awards to any Eligible Person, whether or not he or she has previously received
an Award, except in the case of (a) an ISO, which can only be granted to an
Employee of the Company or any Subsidiary and (b) the Automatic Option Grant
Program described in Section 7 below, which shall be self-executing. The
individuals who shall be eligible to participate in the Automatic Option Grant
Program shall be limited to (i) those individuals who first become non-employee
Directors after the date on which the Company becomes a Public Company, whether
through appointment by the Board or election by the Company's stockholders, and
(ii) those individuals who continue to serve as non-employee Directors at one or
more annual stockholder meetings held after the date on which the Company
becomes a Public Company. A non-employee Director who has previously been
employed by the Company (or any parent or Subsidiary) shall not be eligible to
receive an option grant under the Automatic Option Grant Program at the time he
or she first becomes a non-employee Director, but shall be eligible to receive
periodic option grants under the Automatic Option Grant Program while he or she
continues to serve as a non-employee Director.

                  6. Conditions to Grants.

                     (a) General Conditions. Awards shall be evidenced by
written Award Agreements specifying the number of Shares covered thereby, in
such form as the Committee shall from time to time establish. Award Agreements
may incorporate all or any of the terms of the Plan by reference and shall
comply with and be subject to the following terms and conditions:

                                       3
<PAGE>

                         (i) The Grant Date of an Award shall be the date on
which the Committee grants the Award or such later date as specified in advance
by the Committee;

                         (ii) In the case of an Award of options, the Option
Term shall under no circumstances extend more than ten (10) years after the
Grant Date and shall be subject to earlier termination as herein provided and as
provided in the applicable Award Agreement; and

                         (iii) Any terms and conditions of an Award not set
forth in the Plan shall be set forth in the Award Agreement related to that
Award.

                     (b) Grant of Options. No later than the Grant Date of any
option, the Committee shall determine the Option Price of such option. Subject
to Section 6(c), the Option Price of an option may be the Fair Market Value of a
Share on the Grant Date or may be less than or more than that Fair Market Value.
An option shall be exercisable for unrestricted Shares, unless the Award
Agreement provides that it is exercisable for Restricted Shares.

                     (c) Grant of ISOs. At the time of the grant of any option,
the Committee may, in its discretion, designate that such option shall be made
subject to additional restrictions to permit the option to qualify as an
"incentive stock option" under the requirements of Section 422 of the Code. Any
option designated as an ISO:

                         (i) shall have an Option Price that is not less than
the Fair Market Value of a Share on the Grant Date and, if granted to a Ten
Percent Owner, have an Option Price that is not less than 110% of the Fair
Market Value of a Share on the Grant Date;

                         (ii) shall be for a period of not more than ten (10)
years and, if granted to a Ten Percent Owner, not more than five (5) years, from
the Grant Date and shall be subject to earlier termination as provided herein or
in the applicable Award Agreement;

                         (iii) shall meet the limitations of this subparagraph
6(c)(iii). If the aggregate Fair Market Value of Shares with respect to which
ISOs first become exercisable by a Grantee in any calendar year exceeds the
limit determined in accordance with the provisions of Section 422 of the Code
(the "Limit") taking into account Shares subject to all ISOs granted by the
Company which are held by the Grantee, the excess will be treated as
nonqualified options. To determine whether the Limit is exceeded, the Fair
Market Value of Shares subject to options shall be determined as of the Grant
Dates of the options. In reducing the number of options treated as ISOs to meet
the Limit, the most recently granted options will be reduced first. If a
reduction of simultaneously granted options is necessary to meet the Limit, the
Committee may designate which Shares are to be treated as Shares acquired
pursuant to an ISO;

                         (iv) shall be granted within ten (10) years from the
Effective Date;

                                       4
<PAGE>

                         (v) shall require the Grantee to notify the Committee
of any disposition of any Shares issued upon the exercise of the ISO under the
circumstances described in Section 421(b) of the Code (relating to certain
disqualifying dispositions, a "Disqualifying Disposition"), within ten (10)
business days after such Disqualifying Disposition; and

                         (vi) unless otherwise permitted by the Code, shall by
its terms not be assignable or transferable other than by will or by the laws of
descent and distribution and may be exercised, during the Grantee's lifetime,
only by the Grantee, except that the Grantee may, in accordance with Section 7,
designate in writing a beneficiary to exercise his or her ISOs after the
Grantee's death.

                     (d) Grant of SARs.

                         (i) When granted, SARs may, but need not, be identified
with a specific option, specific Restricted Shares or specific Performance
Shares of the Grantee (including any option, Restricted Shares or Performance
Shares granted on or before the Grant Date of the SARs) in a number equal to or
different from the number of SARs so granted. If SARs are identified with Shares
subject to an option, with Restricted Shares or with Performance Shares, then,
unless otherwise provided in the applicable Award Agreement, the Grantee's
associated SARs shall terminate upon (A) the expiration, termination,
forfeiture, or cancellation of such option, Restricted Shares or Performance
Shares, (B) the exercise of such option or Performance Shares or (C) the date
such Restricted Shares become nonforfeitable.

                         (ii) The Strike Price of any SAR shall equal, for any
SAR that is identified with an option, the Option Price of such option, or for
any other SAR, one hundred percent (100%) of the Fair Market Value of a Share on
the Grant Date of such SAR, except that the Committee may (A) specify a higher
Strike Price in the Award Agreement or (B) provide that the benefit payable upon
exercise of any SAR shall not exceed such percentage of the Fair Market Value of
a Share on such Grant Date as the Committee shall specify.

                     (e) Grant of Performance Shares.

                         (i) Before the grant of Performance Shares, the
Committee shall:

                             (A) determine objective performance goals, which
may, but need not, consist of any one or more of the following goals deemed
appropriate by the Committee: certain scientific milestones, earnings (either in
the aggregate or on a per share basis), operating income, cash flow, EBITDA
(earnings before interest, taxes, depreciation and amortization), return on
equity, indices related to EVA (economic value added), per share rate of return
on the Common Stock (including dividends), market share (in one or more
markets), customer retention rates, market penetration rates, revenues,
reductions in expense levels and the attainment by the Common Stock of a
specified market value for a specified period of time, in each case where
applicable to be determined either on a company-wide basis or in respect of any
one or more business units, and the amount of compensation under the goals
applicable to such grant;

                                       5
<PAGE>

                             (B) designate a period for the measurement of the
extent to which performance goals are attained, which may begin prior to the
Grant Date (the "Performance Period"); and

                             (C) assign a performance percentage to each level
of attainment of performance goals during the Performance Period, with the
percentage applicable to minimum attainment being zero percent and the
percentage applicable to maximum attainment to be determined by the Committee
from time to time (the "Performance Percentage").

                         (ii) If a Grantee is promoted, demoted, or transferred
to a different business unit of the Company during a Performance Period, then,
to the extent the Committee determines any one or more of the performance goals,
Performance Period, or Performance Percentage are no longer appropriate, the
Committee may make any changes thereto as it deems appropriate in order to make
them appropriate.

                         (iii) When granted, Performance Shares may, but need
not, be identified with Shares subject to a specific option, specific Restricted
Shares, or specific SARs of the Grantee granted under the Plan in a number equal
to or different from the number of the Performance Shares so granted. If
Performance Shares are so identified, then, unless otherwise provided in the
applicable Award Agreement, the Grantee's associated Performance Shares shall
terminate upon (A) the expiration, termination, forfeiture, or cancellation of
the option, Restricted Shares, or SARs with which the Performance Shares are
identified, (B) the exercise of such option or SARs or (C) the date Restricted
Shares become nonforfeitable.

                     (f) Grant of Restricted Shares.

                         (i) The Committee shall determine the amount, if any,
that a Grantee shall pay for Restricted Shares, subject to the following
sentence. Except with respect to Restricted Shares that are treasury shares, for
which no payment need be required, the Committee shall require the Grantee to
pay at least the Minimum Consideration for each Restricted Share. Such payment
shall be made in full by the Grantee before the delivery of the shares and in
any event no later than ten (10) business days after the Grant Date.

                         (ii) The Committee may, but need not, provide that all
or any portion of a Grantee's Restricted Shares, or Restricted Shares acquired
upon exercise of an option, shall be forfeited:

                             (A) except as otherwise specified in the Plan or
the Award Agreement, upon the termination of Grantee's employment with, or
Service to, the Company within a specified time period after the Grant Date;

                             (B) if the Company or the Grantee does not achieve
specified performance goals (if any) within a specified time period after the
Grant Date and before the Grantee's termination of employment or service; or

                             (C) upon failure to satisfy such other conditions,
or Grantee's breach of specific conditions, as the Committee may specify in the
Award Agreement.

                                       6
<PAGE>

                         (iii) If Restricted Shares are forfeited and the
Grantee was required to pay for such shares or acquired such Restricted Shares
upon the exercise of an option, the Grantee shall be deemed to have resold such
Restricted Shares to the Company at a price equal to the lesser of (A) the
amount paid by the Grantee for such Restricted Shares and (B) the Fair Market
Value of the Restricted Shares on the date of forfeiture, which shall be paid to
the Grantee in cash as soon as administratively practicable. Such Restricted
Shares shall cease to be outstanding and shall no longer confer on the Grantee
thereof any rights as a shareholder of the Company, from and after the date of
the event causing the forfeiture, whether or not the Grantee accepts the
Company's tender of payment for such Restricted Shares.

                         (iv) The Committee may provide that the certificates
for any Restricted Shares (A) shall be held (together with a stock power
executed in blank by the Grantee) in escrow by the Secretary of the Company
until such Restricted Shares become nonforfeitable or are forfeited or (B) shall
bear an appropriate legend restricting the transfer of such Restricted Shares.
If any Restricted Shares become nonforfeitable, the Company shall cause
certificates for such shares to be issued without such legend.

                     (g) Grant of Stock Bonuses. The Committee may grant Bonus
Shares to any Eligible Person.

                  7. Automatic Option Grant Program.

                     (a) Option Terms.

                         (i) Grant Dates. Option grants shall be made on the
dates specified below:

                             (A) Each individual who is first elected or
appointed as a non-employee Director at any time on or after the date on which
the Company becomes a Public Company shall automatically be granted, on the date
of such initial election or appointment, a non-statutory option to purchase
12,500 Shares, except for the chairman of the board of the Company who shall
automatically be granted on the date of such initial election or appointment, a
non-statutory option to purchase 25,000 Shares, provided that individual has not
previously been in the employment of the Company or any parent or Subsidiary.

                             (B) On the date of each annual stockholder meeting
held after the date on which the Company becomes a Public Company, each
individual who is to continue to serve as a non-employee Director, whether or
not that individual is standing for re-election to the Board at that particular
annual meeting, shall automatically be granted a non-statutory option to
purchase 12,500 Shares, except for the chairman of the Company who shall
automatically be granted a non-statutory option to purchase 25,000 Shares,
provided such individual has served as a non-employee Director for at least six
(6) months. There shall be no limit on the number of such 12,500 or 25,000 share
option grants, as applicable, any one non-employee Director may receive over his
or her period of Board service, and non-employee Directors who have previously
been in the employment of the Company (or any parent or Subsidiary) or who have
otherwise received one or more stock option grants from the Company prior to the
date on which the Company becomes a Public Company shall be eligible to receive
one or more such annual option grants over their period of continued Board
service.

                                       7
<PAGE>

                         (ii) Exercise Price.

                             (A) The exercise price per share shall be equal to
one hundred percent (100%) of the Fair Market Value per Share on the option
grant date.

                             (B) The exercise price shall be payable as set
forth in Section 9 below.

                         (iii) Option Term. Each option shall have a term of ten
(10) years measured from the option grant date.

                         (iv) Exercise and Vesting of Options. Each option shall
be immediately exercisable for any or all of the option shares. However, any
unvested shares purchased under the option shall be subject to repurchase by the
Company, at the lower of (i) the exercise price paid per share or (ii) the Fair
Market Value per Share at the time of repurchase, upon the optionee's cessation
of Board service prior to vesting in those shares. The shares subject to each
initial 12,500 or 25,000 share grant, as applicable, shall vest, and the
Company's repurchase right shall lapse, in a series of three (3) successive
equal annual installments upon the optionee's completion of each year of service
as a Director over the three (3) year period measured from the option grant
date. The shares subject to each annual 12,500 or 25,000 share option grant, as
applicable, shall vest in one installment upon the optionee's completion of the
one (1)-year period of service measured from the grant date.

                         (v) Limited Transferability of Options. Each option
under this Section 7 may be assigned in whole or in part during the optionee's
lifetime to one or more members of the optionee's family or to a trust
established exclusively for one or more such family members or to optionee's
former spouse, to the extent such assignment is in connection with the
optionee's estate plan or pursuant to a domestic relations order. The assigned
portion may only be exercised by the person or persons who acquire a proprietary
interest in the option pursuant to the assignment. The terms applicable to the
assigned portion shall be the same as those in effect for the option immediately
prior to such assignment and shall be set forth in such documents issued to the
assignee as the Committee may deem appropriate. The optionee may also designate
one or more persons as the beneficiary or beneficiaries of his or her
outstanding options under this Section 7, and those options shall, in accordance
with such designation, automatically be transferred to such beneficiary or
beneficiaries upon the optionee's death while holding those options. Such
beneficiary or beneficiaries shall take the transferred options subject to all
the terms and conditions of the applicable agreement evidencing each such
transferred option, including (without limitation) the limited time period
during which the option may be exercised following the optionee's death.

                         (vi) Termination of Board Service. The following
provisions shall govern the exercise of any options held by the optionee at the
time the optionee ceases to serve as a Director:

                                       8
<PAGE>

                             (A) The optionee (or, in the event of optionee's
death, the personal representative of the optionee's estate or the person or
persons to whom the option is transferred pursuant to the optionee's will or the
laws of inheritance or the designated beneficiary or beneficiaries of such
option) shall have a twelve (12)-month period following the date of such
cessation of Board service in which to exercise each such option.

                             (B) During the twelve (12)-month exercise period,
the option may not be exercised in the aggregate for more than the number of
vested Shares for which the option is exercisable at the time of the optionee's
cessation of Board service.

                             (C) Should the optionee cease to serve as a
Director by reason of death or Disability, then all shares at the time subject
to the option shall immediately vest so that such option may, during the twelve
(12)-month exercise period following such cessation of Board service, be
exercised for any or all of those shares as fully vested Shares.

                             (D) In no event shall the option remain exercisable
after the expiration of the option term. Upon the expiration of the twelve
(12)-month exercise period or (if earlier) upon the expiration of the option
term, the option shall terminate and cease to be outstanding for any vested
shares for which the option has not been exercised. However, the option shall,
immediately upon the optionee's cessation of Board service for any reason other
than death or Disability, terminate and cease to be outstanding to the extent
the option is not otherwise at that time exercisable for vested shares.

                     (b) Corporate Transaction.

                         (i) In the event of a Corporation Transaction (as
described in Section 13 below) while the optionee remains a Director, the Shares
at the time subject to each outstanding option held by such optionee under this
Automatic Option Grant Program but not otherwise vested shall automatically vest
in full so that each such option shall, immediately prior to the effective date
of the Corporate Transaction, become exercisable for all the option shares as
fully vested Shares and may be exercised for any or all of those vested shares.
Immediately following the consummation of the Corporate Transaction, each
automatic option grant shall terminate and cease to be outstanding, except to
the extent assumed by the successor corporation (or parent thereof) or otherwise
continued in effect pursuant to the terms of the Corporate Transaction.

                         (ii) In the event of a Corporate Transaction, all
outstanding repurchase rights under this under this Automatic Option Grant
Program shall automatically terminate, and the Shares subject to those
terminated rights shall immediately vest in full.

                         (iii) Upon the occurrence of a Hostile Tender-Offer
while the optionee remains a Director, such optionee shall have a thirty
(30)-day period in which to surrender to the Company each of his or her
outstanding options under this Automatic Option Grant Program. The optionee
shall in return be entitled to a cash distribution from the Company in an amount
equal to the excess of (i) the Tender-Offer Price of the Shares at the time
subject to each surrendered option (whether or not the optionee is otherwise at
the time vested in those shares) over (ii) the aggregate exercise price payable
for such shares. Such cash distribution shall be paid within five (5) days
following the surrender of the option to the Company. No approval or consent of
the Board or any Committee shall be required at the time of the actual option
surrender and cash distribution.

                                       9
<PAGE>

                         (iv) Each option which is assumed in connection with a
Corporate Transaction or otherwise continued in effect shall be appropriately
adjusted, immediately after such Corporate Transaction, to apply to the number
and class of securities which would have been issuable to the optionee in
consummation of such Corporate Transaction had the option been exercised
immediately prior to such Corporate Transaction. Appropriate adjustments shall
also be made to the exercise price payable per share under each outstanding
option, provided the aggregate exercise price payable for such securities shall
remain the same. To the extent the actual holders of the Company's outstanding
Common Stock receive cash consideration for their Common Stock in consummation
of the Corporate Transaction, the successor corporation may, in connection with
the assumption of the outstanding options under the Automatic Option Grant
Program, substitute one or more shares of its own common stock with a fair
market value equivalent to the cash consideration paid per share of Common Stock
in such Corporate Transaction.

                         (v) The grant of options under the Automatic Option
Grant Program shall in no way affect the right of the Company to adjust,
reclassify, reorganize or otherwise change its capital or business structure or
to merge, consolidate, dissolve, liquidate or sell or transfer all or any part
of its business or assets.

                     (c) Remaining Terms. The remaining terms of each option
granted under the Automatic Option Grant Program shall be the same as the terms
in effect for other option grants made under the Plan.

                  8. Transferability. Notwithstanding any contrary provision in
the Plan, all Awards granted hereunder, other than ISOs, may be assigned or
transferred by Grantee to (i) one or more members of Grantee's Immediate Family;
(ii) trusts for the benefit of the Grantee and/or Grantee's Immediate Family;
(iii) entities wholly-owned by Grantee and/or Grantee's Immediate Family; (iv)
charitable institutions; or (v) Grantee's estate or any person who acquires the
right to exercise this Option by bequest or inheritance or by reason of
Grantee's death, by will or by the laws of descent and distribution. Subject to
Section 6(c) in respect of ISOs, a Grantee may, if permitted by the Committee,
in its discretion, (a) designate in writing a beneficiary to exercise an Award
after his or her death (if that designation has been received by the Company
prior to the Grantee's death) and (b) transfer the Award to one or more members
of the Grantee's Immediate Family or any other individuals or entities.

                  9. Exercise.

                     (a) Exercise of Options.

                         (i) Subject to Section 6 and except as otherwise
provided in the applicable Award Agreement, each option shall become exercisable
at such time or times as may be specified by the Committee from time to time.

                                       10
<PAGE>

                         (ii) An option shall be exercised by the delivery to
the Company during the Option Term of (A) a written notice of intent to purchase
a specific number of Shares subject to the option in accordance with the terms
of the option by the person entitled to exercise the option and (B) payment in
full of the Option Price of such specific number of Shares in accordance with
Section 8(a)(iii).

                         (iii) Payment of the Option Price may be made by any
one or more of the following means:

                             (A) cash, check, or wire transfer;

                             (B) with the approval of the Committee, Mature
Shares, valued at their Fair Market Value on the date of exercise;

                             (C) with the approval of the Committee, Restricted
Shares held by the Grantee for at least six (6) months prior to the exercise of
the option, each such share valued at the Fair Market Value of a Share on the
date of exercise; or

                             (D) following the date that the Company becomes a
Public Company, in accordance with procedures previously approved by the
Company, through the sale of the Shares acquired on exercise of the option
through a bank or broker-dealer to whom the Grantee has submitted an irrevocable
notice of exercise and irrevocable instructions to deliver promptly to the
Company the amount of sale or loan proceeds sufficient to pay for such Shares,
together with, if requested by the Company, the amount of federal, state, local
or foreign withholding taxes payable by Grantee by reason of such exercise.

The Committee may in its discretion specify that, if any Restricted Shares are
used to pay the Option Price ("Tendered Restricted Shares"), (A) all the Shares
acquired on exercise of the option shall be subject to the same restrictions as
the Tendered Restricted Shares, determined as of the date of exercise of the
option or (B) a number of Shares acquired on exercise of the option equal to the
number of Tendered Restricted Shares shall be subject to the same restrictions
as the Tendered Restricted Shares, determined as of the date of exercise of the
option.

                     (b) Exercise of SARs.

                         (i) Subject to Section 6(d), and except as otherwise
provided in the applicable Award Agreement, (A) each SAR not identified with any
other Award shall become exercisable with respect to twenty-five percent (25%)
of the Shares subject thereto on each of the first four (4) year anniversaries
of the Grant Date of such SAR and (B) each SAR which is identified with any
other Award shall become exercisable as and to the extent that the Award with
which such SAR is identified may be exercised or becomes nonforfeitable, as the
case may be.

                         (ii) SARs shall be exercised by delivery to the Company
of written notice of intent to exercise a specific number of SARs. Unless
otherwise provided in the applicable Award Agreement, the exercise of SARs which
are identified with Shares subject to an option or Restricted Shares shall
result in the cancellation or forfeiture of such option or Restricted Shares, as
the case may be, to the extent of such exercise.

                                       11
<PAGE>

                         (iii) The benefit for each SAR exercised shall be equal
to (A) the Fair Market Value of a Share on the date of such exercise minus (B)
the Strike Price specified in such SAR. Such benefit shall be payable in cash,
except that the Committee may provide in the Award Agreement that benefits may
be paid wholly or partly in Shares.

                     (c) Payment of Performance Shares. Unless otherwise
provided in the Award Agreement with respect to an Award of Performance Shares,
if the minimum performance goals applicable to such Performance Shares have been
achieved during the applicable Performance Period, then the Company shall pay to
the Grantee of such Award that number of Shares equal to the product of:

                         (i) the sum of (A) number of Performance Shares
specified in the applicable Award Agreement and (B) the number of Shares that
would have been issuable if such Performance Shares had been Shares outstanding
throughout the Performance Period and the stock dividends, cash dividends
(except as otherwise provided in the Award Agreement) and other property paid in
respect of such Shares had been reinvested in additional Shares as of each
dividend payment date,

                         (ii) the Performance Percentage achieved during such
Performance Period.

The Committee may, in its discretion, determine that cash be paid in lieu of
some or all of such Shares. The amount of cash payable in lieu of a Share shall
be determined by valuing such Share at its Fair Market Value on the business day
next preceding the date such cash is to be paid. Payments pursuant to this
Section 8 shall be made as soon as administratively practicable after the end of
the applicable Performance Period. Any Performance Shares with respect to which
the performance goals shall not have been achieved by the end of the applicable
Performance Period shall expire.

                  10. Notification under Section 83(b). If the Grantee, in
connection with the exercise of any option or the grant of Restricted Shares,
makes the election permitted under Section 83(b) of the Code to include in such
Grantee's gross income in the year of transfer the amounts specified in Section
83(b) of the Code, then such Grantee shall notify the Company, in writing, of
such election within ten (10) days after filing the notice of the election with
the Internal Revenue Service, in addition to any filing and notification
required pursuant to regulations issued under Section 83(b) of the Code. The
Committee may, in connection with the grant of an Award or at any time
thereafter, prohibit a Grantee from making the election described in this
Section 9.

                  11. Mandatory Tax Withholding.

                     (a) Whenever under the Plan, Shares are to be delivered
upon exercise or payment of an Award or upon Restricted Shares becoming
nonforfeitable, or any other event with respect to rights and benefits
hereunder, the Company shall be entitled to require (i) that the Grantee remit
an amount in cash, or in the Company's discretion, Mature Shares or any other
form of consideration, sufficient to satisfy all federal, state and local tax
withholding requirements related thereto ("Required Withholding"), (ii) the
withholding of such Required Withholding from compensation otherwise due to the
Grantee or from any Shares due to the Grantee under the Plan or (iii) any
combination of the foregoing.

                                       12
<PAGE>

                     (b) Any Grantee who makes a Disqualifying Disposition or an
election under Section 83(b) of the Code shall remit to the Company an amount
sufficient to satisfy all resulting Required Withholding, except that in lieu of
or in addition to the foregoing, the Company shall have the right to withhold
such Required Withholding from compensation otherwise due to the Grantee or from
any Shares or other payment due to the Grantee under the Plan.

                     (c) After the date that the Company becomes a Public
Company, any surrender by a Section 16 Grantee of previously owned shares of
Common Stock to satisfy tax withholding arising upon exercise of the Award must
comply with the applicable provisions of Rule 16b-3(e).

                  12. Elective Share Withholding. A Grantee may, with the prior
consent of the Committee, elect the withholding by the Company of a portion of
the Shares otherwise deliverable to such Grantee upon the exercise of an Award
or upon Restricted Shares becoming nonforfeitable (each, a "Taxable Event")
having a Fair Market Value equal to the minimum amount necessary to satisfy the
Required Withholding liability attributable to the Taxable Event.

                  13. Corporate Transactions. In the event the Board or the
stockholders of the Company approve a plan of complete liquidation or
dissolution of the Company, all options will terminate immediately prior to the
consummation of such liquidation or dissolution; provided, however, that options
granted pursuant to the Automatic Option Grant Program described in Section 7
above shall be governed by the terms set forth in Section 7. The Committee may,
in its sole discretion, declare that any option shall terminate as of a date
fixed by the Committee and give each Grantee the right to exercise such
Grantee's option as to all or any part of the Shares subject thereto, including
Shares as to which the option would not otherwise be exercisable. In the event
that the Board or the stockholders of the Company approve an agreement for the
sale of all or substantially all of the Company's assets or a merger,
consolidation or similar transaction in which the Company will not be the
surviving entity or will survive as a wholly-owned subsidiary of another entity
(each, a "Corporate Transaction"), the option shall be assumed or an equivalent
option shall be substituted by such successor entity or a parent or subsidiary
of such successor entity, unless the Board determines, in its sole discretion
and in lieu of such assumption or substitution, to take one of the following two
options: (i) fifteen (15) days prior to the scheduled consummation of such
Corporate Transaction, all options shall become immediately vested and
exercisable and shall remain exercisable for a period of fifteen days, or (ii)
cancel any outstanding options and pay or deliver, or cause to be paid or
delivered, to the holder thereof an amount in cash or securities having a value
(as determined by the Board in its sole, good faith discretion) equal to the
product of the number of shares subject to the option multiplied by the amount,
if any, by which (A) the formula or fixed price per share paid to holders of
shares pursuant to such Corporate Transaction exceeds (B) the Option Price
applicable to such shares. With respect to the Company's establishment of an
exercise window, (i) any exercise of an option during such fifteen-day period
shall be conditioned upon the consummation of the contemplated Corporate
Transaction and shall be effective only immediately before the consummation of
such Corporate transaction and (ii) upon consummation of such Corporate
Transaction, the Plan and all outstanding but unexercised options shall
terminate. The Board shall send written notice of the Corporate Transaction that
will result in such a termination to all individuals who hold options not later
than the time at which the Company gives notice thereof to its shareholders.

                                       13
<PAGE>

                  14. Termination of Employment or Service.

                     (a) For Cause. If a Grantee's employment or service is
terminated for Cause, (i) the Grantee's Restricted Shares and SARs that are then
forfeitable shall thereupon be forfeited, subject to the provisions of Section
6(f)(iii) regarding repayment of certain amounts to the Grantee; and (ii) any
unexercised option or Performance Share shall terminate effective immediately
upon such termination of employment or service.

                     (b) On Account of Death. Except as otherwise provided by
the Committee in the Award Agreement, if a Grantee's employment or service
terminates on account of death, then:

                         (i) the Grantee's Restricted Shares that were
forfeitable shall thereupon become nonforfeitable;

                         (ii) any unexercised option or SAR, to the extent
exercisable on the date of such termination of employment or service, may be
exercised, in whole or in part, within the first twelve (12) months after such
termination of employment or service (but only during the Option Term) by (A)
his or her personal representative or by the person to whom the option or SAR,
as applicable, is transferred by will or the applicable laws of descent and
distribution, (B) the Grantee's designated beneficiary, or (C) a Permitted
Transferee; and, to the extent that any such option of SAR was not exercisable
on the date of such termination of employment or service, it will immediately
terminate; and

                         (iii) any unexercised Performance Shares may be
exercised in whole or in part, at any time within six (6) months after such
termination of employment or service on account of the death of the Grantee, by
(A) his or her personal representative or by the person to whom the Performance
Shares are transferred by will or the applicable laws of descent and
distribution, (B) the Grantee's designated beneficiary or (C) a Permitted
Transferee, except that the benefit payable with respect to any Performance
Shares for which the Performance Period has not ended as of the date of such
termination of employment on account of death shall be equal to the product of
Fair Market Value of such Performance Shares multiplied successively by each of
the following:

                             (A) a fraction, the numerator of which is the
number of months (including as a whole month any partial month) that has elapsed
since the beginning of such Performance Period until the date of such
termination of employment or service and the denominator of which is the number
of months (including as a whole month any partial month) in the Performance
Period; and

                             (B) a percentage determined in the discretion of
the Committee that would be earned under the terms of the applicable Award
Agreement assuming that the rate at which the performance goals have been
achieved as of the date of such termination of employment or service would
continue until the end of the Performance Period, or, if the Committee elects to
compute the benefit after the end of the Performance Period, the Performance
Percentage, as determined by the Committee, attained during the Performance
Period for the Performance Share.

                                       14
<PAGE>

                     (c) On Account of Disability. Except as otherwise provided
by the Committee in the Award Agreement, if a Grantee's employment or service
terminates on account of Disability, then:

                         (i) the Grantee's Restricted Shares that were
forfeitable shall thereupon become nonforfeitable;

                         (ii) any unexercised option or SAR, to the extent
exercisable on the date of such termination of employment, may be exercised in
whole or in part, within the first twelve (12) months after such termination of
employment or service (but only during the Option Term) by the Grantee, or by
(A) his or her personal representative or by the person to whom the option or
SAR, as applicable, is transferred by will or the applicable laws of descent and
distribution, (B) the Grantee's designated beneficiary or (C) a Permitted
Transferee; and, to the extent that any such option of SAR was not exercisable
on the date of such termination of employment, it will immediately terminate;
and

                         (iii) any unexercised Performance Shares may be
exercised in whole or in part, at any time within six (6) months after such
termination of employment or service on account of Disability by the Grantee, or
by (A) his personal representative or by the person to whom the Performance
Shares are transferred by will or the applicable laws of descent and
distribution, (B) the Grantee's designated beneficiary or (C) a Permitted
Transferee, except that the benefit payable with respect to any Performance
Shares for which the Performance Period has not ended as of the date of such
termination of employment on account of Disability shall be equal to the product
of the Fair Market Value of the Performance Shares as of the date of exercise
multiplied successively by each of the following:

                             (A) a fraction, the numerator of which is the
number of months (including as a whole month any partial month) that have
elapsed since the beginning of such Performance Period until the date of such
termination of employment or service and the denominator of which is the number
of months (including as a whole month any partial month) in the Performance
Period; and

                             (B) a percentage determined in the discretion of
the Committee that would be earned under the terms of the applicable Award
Agreement assuming that the rate at which the performance goals have been
achieved as of the date of such termination of employment would continue until
the end of the Performance Period, or, if the Committee elects to compute the
benefit after the end of the Performance Period, the Performance Percentage, as
determined by the Committee, attained during the Performance Period for the
Performance Share.

                     (d) Upon a Change of Control. The degree, if any, to which
any Awards shall vest upon a Change of Control or a termination of employment or
service in connection with a Change of Control shall be specified by the
Committee in the applicable Award Agreement.

                                       15
<PAGE>

                     (e) Any Other Reason. Except as otherwise provided by the
Committee in the Award Agreement, if a Grantee's employment or service
terminates for any reason other than for Cause, death, Disability or pursuant to
a Change of Control, then:

                         (i) the Grantee's Restricted Shares (and any SARs
identified therewith), to the extent forfeitable on the date of the Grantee's
termination of employment or service, shall be forfeited on such date;

                         (ii) any unexercised option or SAR (other than a SAR
identified with a Restricted Share or Performance Share), to the extent
exercisable immediately before the Grantee's termination of employment or
service, may be exercised in whole or in part, not later than three (3) months
after such termination of employment or service (but only during the Option
Term); and, to the extent that any such option of SAR was not exercisable on the
date of such termination of employment or service, it will immediately
terminate; and

                         (iii) the Grantee's Performance Shares (and any SARs
identified therewith) shall become nonforfeitable and may be exercised in whole
or in part, but only if and to the extent determined by the Committee.

                     (f) Repurchase Rights. (i) While the Company is not a
Public Company, if a Grantee's employment or service with the Company is
terminated for any reason and the Grantee holds any Common Stock of the Company
acquired upon the exercise of an Award, the Company may, in its discretion,
purchase within two years from the date of termination, all or any portion of
such Common Stock. The purchase price for any Common Stock repurchased by the
Company pursuant to this Section 13(f)(i) shall be the Fair Market Value thereof
on the date of purchase.

                         (ii) Notwithstanding the foregoing, at any time,
including after the Company is a Public Company, if a Grantee's employment or
service with the Company is terminated for Cause or if Grantee breaches any
post-termination covenants set forth in any written agreement between Grantee
and the Company, the Company may, in its discretion, for a period of one year
after the termination for Cause, or the actual discovery by the Company of the
breach, as applicable, and upon 10 days notice to the Grantee, repurchase all or
any portion of any Common Stock acquired by the Grantee upon the Grantee's
exercise of an Award. The purchase price for any Common Stock repurchased by the
Company pursuant to this Section 13 (f)(ii) shall be the lesser of the price
paid to acquire such Common Stock and the Fair Market Value thereof on the date
of such purchase by the Company.

                  15. Plans of Foreign Subsidiaries. The Committee may authorize
any foreign Subsidiary to adopt a plan for granting Awards ("Foreign Plan"). All
Awards granted under such Foreign Plan shall be treated as grants under the
Plan. Such Foreign Plans shall have such provisions as the Committee permits not
inconsistent with the provisions of the Plan. Awards granted under a Foreign
Plan shall be governed by the terms of the Plan, except to the extent that the
provisions of the Foreign Plan are more restrictive than the provisions of the
Plan, in which case the Foreign Plan shall control.

                                       16
<PAGE>

                  16. Substituted Awards. If the Committee cancels any Award
(whether granted under this Plan or any plan of any entity acquired by the
Company or a Subsidiary), the Committee may, in its discretion, substitute a new
Award therefor upon such terms and conditions consistent with the Plan as the
Committee may determine, except that (a) the Option Price of any new option, and
the Strike Price of any new SAR, shall not be less than one hundred percent
(100%) (one hundred ten percent (110%) in the case of an incentive stock option
granted to a Ten Percent Owner) of the Fair Market Value of a Share on the date
of the grant of the new Award; and (b) the Grant Date of the new Award shall be
the date on which such new Award is granted.

                  17. Securities Law Matters.

                     (a) If the Committee deems it necessary to comply with any
applicable securities law, the Committee may require a written investment intent
representation by the Grantee and may require that a restrictive legend be
affixed to certificates for Shares. If, based upon the advice of counsel to the
Company, the Committee determines that the exercise or nonforfeitability of, or
delivery of benefits pursuant to, any Award would violate any applicable
provision of (i) federal or state securities or blue-sky laws or regulations or
(ii) the listing requirements of any national exchange or national market system
on which are listed any of the Company's equity securities, then the Committee
may postpone any such exercise, nonforfeitability or delivery, as applicable,
but the Company shall use all reasonable efforts to cause such exercise,
nonforfeitability or delivery to comply with all such provisions at the earliest
practicable date.

                     (b) Grants of options to Section 16 Grantees shall comply
with Rule 16b-3 and shall contain such additional conditions or restrictions as
may be required thereunder for such grants to qualify for exemption from
liability under Section 16(b) of the 1934 Act.

                  18. No Employment Rights. Neither the establishment of the
Plan nor the grant of any Award shall (a) give any Grantee the right to remain
employed or otherwise engaged, hired or retained by the Company or any
Subsidiary, or entitle any Grantee to any benefits not specifically provided by
the Plan or (b) modify the right of the Company or any Subsidiary to modify,
amend, or terminate any employee benefit plan.

                  19. No Rights as a Shareholder. A Grantee shall not have any
rights as a shareholder of the Company with respect to the Shares (other than
Restricted Shares) which may be deliverable upon exercise or payment of such
Award until such shares have been delivered to him or her. Restricted Shares,
whether held by a Grantee or in escrow by the Company, shall confer on the
Grantee all rights of a shareholder of the Company, except as otherwise provided
in the Plan or in the applicable Award Agreement. At the time of a grant of
Restricted Shares, the Committee may require the payment of cash dividends
thereon to be deferred and, if the Committee so determines, reinvested in
additional Restricted Shares. Stock dividends or deferred cash dividends issued
with respect to Restricted Shares shall be subject to the same restrictions and
other terms as apply to the Restricted Shares with respect to which such
dividends are issued. The Committee may in its discretion provide for payment of
interest on deferred cash dividends.

                                       17
<PAGE>

                  20. Nature of Payments. Awards shall be special incentive
payments to the Grantee and shall not be taken into account in computing the
amount of salary or compensation of the Grantee for purposes of determining any
pension, retirement, death, or other benefit under (a) any pension, retirement,
profit-sharing, bonus, insurance, or other employee benefit plan of the Company
or any Subsidiary or (b) any agreement between (i) the Company or any Subsidiary
and (ii) the Grantee, except as such plan or agreement shall otherwise expressly
provide.

                  21. Non-Uniform Determinations. The Committee's determinations
under the Plan need not be uniform and may be made by the Committee selectively
among persons who receive, or are eligible to receive, Awards, whether or not
such persons are similarly situated. Without limiting the generality of the
foregoing, the Committee shall be entitled, to enter into non-uniform and
selective Award Agreements as to (a) the identity of the Grantees, (b) the terms
and provisions of Awards and (c) the treatment of terminations of employment or
service.

                  22. Adjustments. The Committee shall make equitable adjustment
of:

                     (a) the aggregate number of Shares available under the Plan
for Awards and the aggregate number of Shares for which Awards may be granted to
any individual Grantee in any calendar year pursuant to the second sentence of
Section 2;

                     (b) the number of Shares, SARs or Performance Shares
covered by an Award; and

                     (c) the Option Price of all outstanding options and the
Strike Price of all outstanding SARs;

to reflect a stock dividend, stock split, reverse stock split, share
combination, recapitalization, merger, consolidation, spin-off, split-off,
reorganization, rights offering, liquidation or similar event, of or by the
Company.

                  23. Amendment of the Plan. The Committee may from time to
time, in its discretion, amend the Plan without the approval of the Company's
shareholders, except (a) as such shareholder approval may be required under the
listing requirements of any securities exchange or national market system on
which are listed the Company's equity securities and (b) that the Committee may
not without the approval of the Company's shareholders amend the Plan to
increase the total number of shares reserved for the purposes of the Plan (other
than in accordance with Section 21).

                  24. Termination of the Plan. The Plan shall continue in effect
until the earlier of its termination by the Committee or the date on which all
of the shares of Common Stock available for issuance under the Plan have been
issued and all restrictions on such shares under the terms of the Plan and the
agreements evidencing Awards granted under the Plan have lapsed. However, all
Awards shall be granted, if at all, within ten (10) years from the earlier of
the date the Plan is adopted by the Committee or the date the Plan is duly
approved by the shareholders of the Company. Notwithstanding the foregoing, if
the maximum number of shares of Common Stock issuable pursuant to the Plan has
been increased at any time, all Awards shall be granted, if at all, no later
than the last day preceding the ten (10) year anniversary of the earlier of (a)
the date on which the latest such increase in the maximum number of shares of
Common Stock issuable under the Plan was approved by the shareholders of the
Company or (b) the date such amendment was adopted by the Committee. No
termination shall affect any Award then outstanding under the Plan.

                                       18
<PAGE>

                  25. No Illegal Transactions. The Plan and all Awards granted
pursuant to it are subject to all applicable laws and regulations.
Notwithstanding any provision of the Plan or any Award, Grantees shall not be
entitled to exercise, or receive benefits under, any Award, and the Company
shall not be obligated to deliver any Shares or deliver benefits to a Grantee,
if such exercise or delivery would constitute a violation by the Grantee or the
Company of any applicable law or regulation.

                  26. Constructive Sales. The Grantee shall not directly or
indirectly, through related parties or otherwise, sell "short" or "short against
the box" (as those terms are generally understood in the securities markets), or
otherwise directly or indirectly (through derivative instruments or otherwise)
dispose of or hedge, any securities of the Company issuable upon exercise of
such Grantee's Award(s). The foregoing provision may, at the discretion of the
Committee, be reflected in the individual Award Agreements governing the terms
and conditions of the Awards granted by the Company to the Grantees (which shall
be entered into following the grant of such Awards by the Committee).

                  27. Definitions. The terms set forth below have the indicated
meanings which are applicable to both the singular and plural forms thereof:

                     (a) "Award" shall mean options, including ISOs, Restricted
Shares, Bonus Shares, SARs or Performance Shares granted under the Plan.

                     (b) "Award Agreement" shall mean the written agreement by
which an Award shall be evidenced.

                     (c) "Board" shall mean the Board of Directors of the
Company.

                     (d) "Bonus Shares" shall mean Shares that are awarded to a
Grantee without cost and without restrictions.

                     (e) "Cause", with respect to any employee or consultant of
the Company shall have the meaning set forth in such person's employment,
consulting or other applicable agreement, or, in the absence of any such
agreement or if such term is not defined in any such agreement, shall mean any
one or more of the following, as determined by the Committee (in the case of a
Section 16 Grantee) or the Chief Executive Officer or President of the Company
(in the case of any other Grantee):

                         (i) a Grantee's commission of a crime that is likely to
result in injury to the Company or a Subsidiary;

                                       19
<PAGE>

                         (ii) the material violation by the Grantee of written
policies of the Company or a Subsidiary;

                         (iii) the habitual neglect by the Grantee in the
performance of his or her duties to the Company or a Subsidiary; or

                         (iv) a Grantee's willful misconduct or inaction in
connection with his or her duties to the Company or a Subsidiary.

                     (f) "Change of Control" shall mean the occurrence of any of
the following events:

                         (i) Any "person", as such term is currently used in
Section 13(d) or 14(d) of the 1934 Act, other than any employee benefit plan of
the Company, becomes a "beneficial owner" (as such term is currently used in
Rule 13d-3 promulgated under the 1934 Act) of 50% or more of the number of
shares of the Company's voting stock;

                         (ii) The Board adopts any plan of liquidation providing
for the distribution of all or substantially all of the Company's assets;

                         (iii) All or substantially all of the assets or
business of the Company is disposed of pursuant to a sale, merger, consolidation
or other transaction, unless the shareholders of the Company immediately prior
to such transaction beneficially own (within the meaning of Rule 13d-3
promulgated under the 1934 Act) as a result of their ownership of stock in the
Company, at least 50% of the number of shares of voting stock or other voting
equity of the entity or entities that succeed to the business of the Company; or

                         (iv) The Company combines with another company and is
the surviving corporation but, immediately after the combination, the
shareholders of the Company immediately before such transaction beneficially own
(within the meaning of Rule 13d-3 promulgated under the 1934 Act) as a result of
their ownership of stock in the Company, less than 50% of the number of shares
of voting stock of the combined company.

                     (g) "Code" shall mean the Internal Revenue Code of 1986, as
amended or superseded, and the regulations and rulings thereunder. Reference to
a particular section of the Code shall include references to successor
provisions.

                     (h) "Committee" shall mean the committee of the Board
appointed pursuant to Section 3(a), or if not so appointed, shall mean the
entire Board.

                     (i) "Common Stock" shall mean the common stock, $.001 par
value per share, of the Company.

                     (j) "Consultant" shall mean any person, including a
Director, who is engaged by the Company or any parent, Subsidiary or affiliate
thereof, to render services to or for the benefit of the Company and is
compensated for such services.

                     (k) "Director" shall mean a member of the Board.

                                       20
<PAGE>

                     (l) "Disability" shall mean a permanent and total
disability, within the meaning of Section 22(e)(3) of the Code.

                     (m) "Effective Date" shall mean the date set forth in the
first paragraph hereof.

                     (n) "Eligible Person" shall mean any Employee, Consultant
or Director of the Company or any Subsidiary, including any prospective Employee
or Employee on an approved leave of absence or layoff, if such leave or layoff
does not qualify as a Disability.

                     (o) "Employee" shall mean any person treated as an employee
(including officers and directors) in the records of the Company and who is
subject to the control and direction of the Company with regard to both the work
to be performed and the manner and method of performance. The payment of a
director's fee by the Company to a Director shall not be sufficient to
constitute "employment" of the Director by the Company.

                     (p) "Fair Market Value" per share of Common Stock on any
relevant date shall mean such value as determined in accordance with the
following provisions:

                         (i) If the Common Stock is at that time listed on a
national securities exchange, then the Fair Market Value shall mean the closing
selling price per share of Common Stock on the exchange on which such Common
Stock is principally traded on the relevant date or, if there were no sales on
that date, the closing selling price of such Common Stock on the last preceding
date on which there were sales.

                         (ii) If the Common Stock is at that time traded on the
Nasdaq National Market(R), Nasdaq Small Cap MarketSM or OTC Bulletin Board(R),
as the case may be, then the Fair Market Value shall mean the closing selling
price per share of Common Stock on the relevant date, as the price is reported
by the National Association of Securities Dealers, Inc., on the Nasdaq National
Market(R), Nasdaq Small Cap MarketSM or OTC Bulletin Board(R), as the case may
be, or any successor system. If there is no closing selling price for the Common
Stock on the relevant date, then the Fair Market Value shall mean the closing
selling price on the last preceding date for which such quotation exists.

                         (iii) If the Common Stock is neither listed on any
national securities exchange nor traded on the Nasdaq National Market(R), Nasdaq
Small Cap MarketSM or OTC Bulletin Board(R), then the Fair Market Value shall
mean the value per share of Common Stock as determined by the Board after taking
into account such factors as the Board shall in good faith deem appropriate.

                     (q) "Grant Date" shall have the meaning specified in
Section 6(a)(i).

                     (r) "Grantee" shall mean an individual who has been granted
an Award or any Permitted Transferee.

                     (s) "Hostile Tender-Offer" shall mean the acquisition,
directly or indirectly, by any person or related group of persons (other than
the Company or a person that directly or indirectly controls, is controlled by,
or is under common control with, the Company) of beneficial ownership (within
the meaning of Rule 13d-3 of the 1934 Act) of securities possessing more than
fifty percent (50%) of the total combined voting power of the Company's
outstanding securities pursuant to a tender or exchange offer made directly to
the Company's stockholders which the Board does not recommend such stockholders
to accept.

                                       21
<PAGE>

                     (t) "Immediate Family" shall mean, with respect to a
particular Grantee, the Grantee's spouse, children and grandchildren.

                     (u) "ISO" shall mean an incentive stock option within the
meaning of Section 422 of the Code.

                     (v) "Mature Shares" shall mean Shares for which the holder
thereof has good title, free and clear of all liens, encumbrances and
restrictions, and which such holder has held for at least six (6) months.

                     (w) "Minimum Consideration" shall mean $.001 per Share or
such other amount that is from time to time considered to be capital for
purposes of Section 154 of the Delaware General Corporation Law.

                     (x) "1934 Act" shall mean the Securities Exchange Act of
1934, as amended. References to a particular section of the 1934 Act or rule
thereunder, include references to successor provisions.

                     (y) "Option Price" shall mean the per share exercise price
of an option.

                     (z) "Option Term" shall mean the period beginning on the
Grant Date of an option and ending on the expiration date of such option, as
specified in the Award Agreement for such option and as may, in the discretion
of the Committee and consistent with the provisions of the Plan, be extended
from time to time.

                     (aa) "Performance Shares" shall mean an Award to a Grantee
pursuant to Section 6(e).

                     (bb) "Permitted Transferee" shall mean a person to whom an
Award may be transferred or assigned in accordance with Section 7.

                     (cc) "Public Company" shall mean any entity issuing any
class of equity securities that is required to be registered under Section 12 or
15 of the 1934 Act.

                     (dd) "Restricted Shares" shall mean Shares that are subject
to forfeiture if the Grantee does not satisfy the conditions specified in the
Award Agreement applicable to those Shares.

                     (ee) "Rule 16b-3" shall mean Rule 16b-3 as promulgated
under the 1934 Act, as amended from time to time, together with any successor
rule.

                     (ff) "SAR" shall mean a stock appreciation right.

                                       22
<PAGE>

                     (gg) "Section 16 Grantee" shall mean a person who is
subject to potential liability under Section 16(b) of the 1934 Act with respect
to transactions involving equity securities of the Company.

                     (hh) "Share" shall mean a share of Common Stock.

                     (ii) "Strike Price" shall have the meaning specified in
Section 6(d)(ii).

                     (jj) "Subsidiary" shall mean a subsidiary corporation as
defined in Section 424(f) of the Code (with the Company being treated as the
employer corporation for purposes of this definition).

                     (kk) "Tender-Offer Price" shall mean the greater of (i) the
Fair Market Value per share of Common Stock on the date the option is
surrendered to the Company in connection with a Hostile Tender-Offer or (ii) the
highest reported price per share of Common Stock paid by the tender offeror in
effecting such Hostile Tender-Offer. However, if the surrendered option is an
ISO, the Tender-Offer Price shall not exceed the clause (i) price per share.

                     (ll) "Ten Percent Owner" shall mean a person who owns
capital stock (including stock treated as owned under Section 424(d) of the
Code) possessing more than ten percent of the total combined Voting Power of all
classes of capital stock of the Company or any Subsidiary.

                     (mm) "Voting Power" shall mean the combined voting power of
the then-outstanding securities of the Company entitled to vote generally in the
election of directors.

                  28. Controlling Law. The law of the State of Delaware, except
its law with respect to choice of law, shall control all matters relating to the
Plan.

                  29. Severability. If any part of the Plan is declared by any
court or governmental authority to be unlawful or invalid, such unlawfulness or
invalidity shall not invalidate any other part of the Plan. Any Section or part
of a Section so declared to be unlawful or invalid shall, if possible, be
construed in a manner which will given effect to the terms of such Section to
the fullest extent possible while remaining lawful and valid.

                                       23

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00037-of-00352.parquet"}]]